These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 12523487)

  • 1. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
    Barden N
    J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats.
    Szymańska M; Budziszewska B; Jaworska-Feil L; Basta-Kaim A; Kubera M; Leśkiewicz M; Regulska M; Lasoń W
    Psychoneuroendocrinology; 2009 Jul; 34(6):822-32. PubMed ID: 19195790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptors in depression.
    Pariante CM; Nemeroff CB; Miller AH
    Isr J Med Sci; 1995 Dec; 31(12):705-12. PubMed ID: 8543464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis.
    Ito N; Nagai T; Yabe T; Nunome S; Hanawa T; Yamada H
    Phytomedicine; 2006 Nov; 13(9-10):658-67. PubMed ID: 16516452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agents in development for the treatment of depression.
    Grady MM; Stahl SM
    CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
    Heydendael W; Jacobson L
    Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
    Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoids of St. John's Wort reduce HPA axis function in the rat.
    Butterweck V; Hegger M; Winterhoff H
    Planta Med; 2004 Oct; 70(10):1008-11. PubMed ID: 15490333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.
    Schüle C; Baghai TC; Eser D; Rupprecht R
    Expert Rev Neurother; 2009 Jul; 9(7):1005-19. PubMed ID: 19589050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
    Maric NP; Adzic M
    Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
    Binder EB; Salyakina D; Lichtner P; Wochnik GM; Ising M; Pütz B; Papiol S; Seaman S; Lucae S; Kohli MA; Nickel T; Künzel HE; Fuchs B; Majer M; Pfennig A; Kern N; Brunner J; Modell S; Baghai T; Deiml T; Zill P; Bondy B; Rupprecht R; Messer T; Köhnlein O; Dabitz H; Brückl T; Müller N; Pfister H; Lieb R; Mueller JC; Lõhmussaar E; Strom TM; Bettecken T; Meitinger T; Uhr M; Rein T; Holsboer F; Muller-Myhsok B
    Nat Genet; 2004 Dec; 36(12):1319-25. PubMed ID: 15565110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
    Cubała WJ; Landowski J
    Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior.
    Boyle MP; Brewer JA; Funatsu M; Wozniak DF; Tsien JZ; Izumi Y; Muglia LJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):473-8. PubMed ID: 15623560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.